Provider review
VyrarX review
A published LegitScript seal ID — but the compounding pharmacy itself is unnamed
Semaglutide from $179 a month and tirzepatide from $329, with messaging, a titration plan, coaching and shipping included, in 47 states. It does not name the three it excludes, nor the pharmacy, nor a single clinician.
Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.
On this page
The verdict
VyrarX backs its claims with a working LegitScript verification link, and includes genuinely useful extras in every plan — 1:1 provider messaging, a personalized titration plan, and nutrition coaching — at $179/month for semaglutide. Tirzepatide, at $329/month, sits at the high end of the compounded market. The gaps: no compounding pharmacy is named on any public page, no physician names or clinical leadership are disclosed, and the site's own "47 states" banner doesn't say which three states are excluded.
VyrarX is not ranked on any of our rankings. This is a standalone read of what the company publishes about itself — the providers we do rank in this category are on our semaglutide provider ranking. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.
Who it is for, and who it is not
A good fit if
- You want 1:1 direct provider messaging and nutrition coaching bundled into every plan
- You want a domain-specific LegitScript seal
- You want free direct-to-door shipping included
Look elsewhere if
- You want tirzepatide priced competitively rather than at the high end of the compounded market
- You want a named compounding pharmacy or disclosed clinical leadership
- You need to confirm your specific state is one of the 47 covered before signing up
What it actually costs
What they advertise
Compounded semaglutide from $179/month on vyrarx.com.
What you actually pay, month to month
$179/month for semaglutide; tirzepatide runs $329/month.
Checked live on VyrarX's own site at https://vyrarx.com in August 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.
What is included
The cheapest headline number in this category is often the one with the least attached to it. Here is what VyrarX bundles in, and what it does not.
Clinician consult
Provider review completed within 24 hours of intake
per the homepage.
Bloodwork / labs
Not published.
Follow-ups and dose changes
1:1 direct provider messaging and personalized titration plan.
Human support
Nutrition coaching included.
Injection supplies
Not itemized.
Shipping
Free direct-to-door shipping.
Pharmacy, labs and oversight
The pharmacy
Not named on any public page.
Oversight
1:1 direct provider messaging and personalized titration plan.
Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.
Where you can get it
47 states via the homepage banner — the 3 excluded states aren't named anywhere on the site.
The honest cons
The part they would rather you skipped
VyrarX's $179/month semaglutide price includes genuinely useful extras — but the compounding pharmacy itself is never named on any public page, no physician or clinical leadership is disclosed, and the "47 states" banner doesn't say which three states are left out.
- Tirzepatide at $329/month is at the high end of the compounded market
- Compounding pharmacy not named on any public page
- No physician names or clinical leadership disclosed publicly
- 3 excluded states aren't named — only "47 states" is confirmed
None of this is unique to VyrarX — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are cataloged in our vendor red-flags guide.
How it compares
The providers we rank on our semaglutide provider ranking, in the order that ranking ranks them. VyrarX is not among them: it is reviewed here, not ranked there, and we would rather show you the comparison than pretend the two are the same thing.
- COCollectiveThe cheapest medication price here, on a membership the headline omits
- CoreAge RxOne price that does not move when your dose does
- BHBodybuilding Health+The deep peptide catalog is gone; the GLP-1 pricing got better
- RxSpan MDOral tablet only, at a real $179 monthly rate
- Enhance MDWrites a flat-price-at-every-dose policy down — and charges near the top for it
- Found HealthInsurance-integrated, unlike every cash-only compounder here — but $99 needs a prepay
- Direct MedsThe plainest price mechanics on either ranking, from a company with an FDA warning letter
- Synergy RxPublishes a starting number, and nothing about what it commits you to
13 more providers rank on our semaglutide provider ranking — see the full ranking. Every provider we review →
Read this before you buy
A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.
Facts on this page reflect VyrarX's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on VyrarX's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.